The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engineering, development and ...
Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...
Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...
Pipe17, the AI-native Order Operations Platform, announced today comprehensive post-checkout agentic commerce solutions for enterprise brands and third-party logistics providers (3PLs). Businesses ...
India’s foreign exchange reserves stood at about 687.26 billion in the portfolio (as of December 12, 2025). That is a good ...
A near-death trauma and immigrant experience informs Guadalupe Hayes-Mota’s work developing ethical frameworks for all ...
Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
Pharmaceutical Technology on MSN
FDA increases manufacturing flexibility for cell and gene therapies
Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.
Phase 3 X-TOLE2 topline data for azetukalner in FOS expected March 2026 followed by anticipated NDA submission in H2 2026Five ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results